http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020030745-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b8efbe17a2f7849f41e115be4ef3de11 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_523523e4857f980c860a0d49e77ed0ec |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6893 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-74 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-74 |
| filingDate | 2019-08-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7c04c71a5ac05df3fe2f5638389820ad http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_37bc9ef5967da360e29ed27949a41702 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0ba524743ff6f1ee406e6f340d864f02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e698f5ab57ae07ef722a060c268b8a23 |
| publicationDate | 2020-02-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2020030745-A1 |
| titleOfInvention | Pro-adm for prognosing the risk of a medical condition requiring hospitalization in patients with symptoms of infectious disease |
| abstract | The invention relates to a method for therapy guidance, stratification and/or control in a patient with symptoms of an infectious disease, comprising a prognosis of disease progression, the method comprising: providing a sample from said patient, and determining a level of proADM or fragment(s) thereof in said sample, wherein a low risk level of proADM level or fragment(s) thereof in said sample indicates that the patient is not at risk of a disease progression to a condition that requires hospitalization, wherein said low risk level is preferably equal or below 1.2 nmol/l ± 20%, and/or wherein a high risk level of proADM level or fragment(s) thereof in said sample indicates that the patient is at risk of a disease progression to a condition that requires hospitalization, wherein said high risk level is preferably above 1.2 nmol/l ± 20%. The invention further relates to a test kit for carrying out the method. |
| priorityDate | 2018-08-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 1625.